TROG Cancer Research
Members Login   CQMS Login  

Closed gynaecological trials

Trials closed to recruitment

TROG 08.04 (PORTEC3) - this study compares radiation plus chemotherapy with radiation alone in treating women with endometrial cancer that is classified as high risk or advanced stage. This study is open to women with endometrial cancer that is classified as high risk or is at an advanced stage.

Primary sponsor: Dutch Cooperative Gynecologic Oncology Group (DGOG)
Collaborating groups: TROG; Cancer Research UK (CRUK); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); MaNGO Group (Italy); Australia New Zealand Gynaecological Oncology Group (ANZGOG)


TROG 04.02 - the aim of this study was to assess the number of patients with cervical cancers that have more invasive disease within the uterus.

Primary Sponsor: TROG

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.